安必平(688393.SH):擬以1000萬元參投基金、其重點投資於醫療健康產業優質成長階段的企業
格隆匯11月8日丨安必平(688393.SH)公佈,為更好地實施公司戰略規劃,配合公司在醫療健康領域的產業生態佈局,賦能產業資源和研發資源,增強產業協同的效應,藉助專業投資機構的經驗和資源,拓寬投資方式和渠道,提升公司整體競爭力。公司全資子公司安必平投資擬以自有資金出資1000萬元人民幣,持有蘇州高特佳信銀匯鑫股權投資合夥企業(有限合夥)(暫定名,以工商登記部門最終核定為準,“高特佳匯鑫”)2%的份額,重點投資於醫療健康產業優質成長階段的企業。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.